AbbVie
-
Yahoo Finance Analysis: Three Dividend Stocks Are Currently "No-Brainer" Buys, Including Healthcare Giant AbbVie
Yahoo Finance analysis points out that in dividend investing, in addition to yield, standards such as dividend coverage ratio, dividend growth, and valuation also need attention. The article recommend
-
AbbVie highlights growth drivers SKYRIZI and RINVOQ, pipeline catalysts, and maintained high-single-digit revenue growth outlook at Wells Fargo conference
AbbVie executives outlined growth plans across immunology, oncology, and neuroscience at a Wells Fargo conference, emphasizing continued momentum for its SKYRIZI and RINVOQ franchises, a pipeline of c
-
AbbVie is considered a better healthcare stock pick than Johnson & Johnson for 2026, with its net income projected to surge to $14.6 billion.
An analysis from Yahoo Finance highlights AbbVie's impressive R&D pipeline and higher upside potential, projecting its net income to surge from $4.2 billion to $14.6 billion this fiscal year, with sal
-
Yahoo Finance analysis points out that three healthcare stocks, Eli Lilly, Johnson & Johnson, and AbbVie, are worth watching in August due to their relatively poor market performance but strong fundamentals.
The analysis suggests that although the healthcare sector has underperformed the S&P 500 year-to-date, it has led all sectors over the past three months. Specifically, Eli Lilly's Q2 revenue increased
-
JPMorgan says one of the market’s ‘most durable growth’ sectors has been passed over for AI
JPMorgan states that one of the market’s “most durable growth” sectors has been overlooked by investors in favor of artificial intelligence (AI). The bank lists Eli Lilly, AbbVie, and Danaher Corporat
-
Yahoo Finance Analysis: Three Dividend Stocks Are Currently "No-Brainer" Buys, Including Healthcare Giant AbbVie
Yahoo Finance analysis points out that in dividend investing, in addition to yield, standards such as dividend coverage ratio, dividend growth, and valuation also need attention. The article recommend
-
AbbVie highlights growth drivers SKYRIZI and RINVOQ, pipeline catalysts, and maintained high-single-digit revenue growth outlook at Wells Fargo conference
AbbVie executives outlined growth plans across immunology, oncology, and neuroscience at a Wells Fargo conference, emphasizing continued momentum for its SKYRIZI and RINVOQ franchises, a pipeline of c
-
AbbVie is considered a better healthcare stock pick than Johnson & Johnson for 2026, with its net income projected to surge to $14.6 billion.
An analysis from Yahoo Finance highlights AbbVie's impressive R&D pipeline and higher upside potential, projecting its net income to surge from $4.2 billion to $14.6 billion this fiscal year, with sal
-
Yahoo Finance analysis points out that three healthcare stocks, Eli Lilly, Johnson & Johnson, and AbbVie, are worth watching in August due to their relatively poor market performance but strong fundamentals.
The analysis suggests that although the healthcare sector has underperformed the S&P 500 year-to-date, it has led all sectors over the past three months. Specifically, Eli Lilly's Q2 revenue increased
-
JPMorgan says one of the market’s ‘most durable growth’ sectors has been passed over for AI
JPMorgan states that one of the market’s “most durable growth” sectors has been overlooked by investors in favor of artificial intelligence (AI). The bank lists Eli Lilly, AbbVie, and Danaher Corporat
- No data
AbbVie
24H Trending
-
1
Samsung Electronics is down 4.44% from its previous close, now trading at ₩231,250.
-
2
Samsung Electronics fell 5.99% from its previous close, now trading at ₩227,500.
-
3
Nikkei Asia: Iranian separatists intensify attacks and seize territory in response to a potential full-scale US assault.
-
4
What is FLOW? An Analysis of the Flow Blockchain Ecosystem and Its Current Status
-
5
China's tech stocks lose luster as STAR 50 Index plunges over 40% from July peak, CATL falls 37% YTD amid AI profit doubts
-
6
LS Cable subsidiary Gaon Cable secures W120b ($90m) US AI data center cable deal
-
7
Report: Hedge Funds Exit Bitcoin ETF Arbitrage Trades, Sovereign Wealth Funds and Retail Investors Step In
-
8
Obama criticizes Trump's Iran war, citing US vulnerability and rising oil prices
-
9
Thailand's Kasikornbank taps AI to expand wealth management customer base
-
10
Iran's Islamic Revolutionary Guard Corps claims to have shot down a US-made MQ-1 drone near the Strait of Hormuz.
Markets Today
Recommended Reading

